Cargando...

Cebranopadol Blocks the Escalation of Cocaine Intake and Conditioned Reinstatement of Cocaine Seeking in Rats

Cebranopadol is a novel agonist of nociceptin/orphanin FQ peptide (NOP) and opioid receptors with analgesic properties that is being evaluated in clinical Phase 2 and Phase 3 trials for the treatment of chronic and acute pain. Recent evidence indicates that the combination of opioid and NOP receptor...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Pharmacol Exp Ther
Main Authors: de Guglielmo, Giordano, Matzeu, Alessandra, Kononoff, Jenni, Mattioni, Julia, Martin-Fardon, Rémi, George, Olivier
Formato: Artigo
Idioma:Inglês
Publicado: The American Society for Pharmacology and Experimental Therapeutics 2017
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5539589/
https://ncbi.nlm.nih.gov/pubmed/28645915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.117.241042
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!